NCT07484789

Brief Summary

Major depression is a mental illness that seriously threatens public health, leading to disability, reduced quality of life, economic burden, and premature death. It is estimated that 18.4% of the world's population lived with depression between 2005 and 2015, and it is projected to be a leading cause of global disease burden by 2030. Major depressive disorder manifests with symptoms such as decreased interest and desire, a depressed mood, increased or decreased sleep and appetite, feelings of worthlessness and guilt, decreased energy, suicidal thoughts and attempts, leading to significant impairment in functioning. Choosing the appropriate treatment for depression and taking measures to improve the individual's functionality quickly, shorten hospital stays, and reduce the number of hospitalizations are crucial. In addition to pharmacological treatment, clinical guidelines recommend the combined use of pharmacological and psychosocial interventions in the treatment of depression. The mindfulness-based cognitive therapy, which forms the basis of the psychoeducation planned for this study, was developed as an 8-week group approach. Theoretical studies examining emotion regulation mechanisms have indicated that mindful awareness is a fundamental mechanism for emotion regulation. The literature suggests a negative correlation between mindful awareness and the severity of depressive symptoms and difficulty in emotion regulation. Furthermore, despite numerous descriptive, correlational, and experimental studies on major depression, no studies have been found demonstrating the effect of mindful awareness-based psychoeducation on emotion regulation difficulties, distress tolerance, and symptom severity in patients diagnosed with major depression. This study, therefore, differs from existing research and will make a significant contribution to the literature.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Oct 2027

First Submitted

Initial submission to the registry

March 10, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

1 month

First QC Date

March 10, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

depressionmindfulnesspsychiatric nursing

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory (BDI)

    Beck Depression Inventory (BDI): Developed by Beck in 1961, the Beck Depression Inventory is designed to measure the risk of depression, the level of depressive symptoms, and variations in severity in adults. Consisting of 21 items, each item in the BDI has four options. Each item is scored between 0 and 3. The sum of these scores yields a depression score. The highest possible score is 63, and a higher total score indicates a higher severity of depression. In the Turkish adaptation of the BDI by Hisli (1988, 1989), the Cronbach α reliability coefficient was determined as α=0.80 in the validity and reliability study.

    1.5 years

Secondary Outcomes (3)

  • Distress Tolerance Scale (DTS):

    1.5 years

  • Personal Information Form

    1.5 years

  • Difficulties in Emotion Regulation Scale (DDRS)

    1.5 years

Study Arms (2)

control group

NO INTERVENTION

The control group will be administered the pre-test scales. Participants will not receive any intervention. Then, the same scales will be administered as a post-test, and a follow-up test using the same scales will be conducted two months later.

experimental group

ACTIVE COMPARATOR

Pre-test scales will be administered to participants in the experimental group. Participants will receive mindfulness-based psychoeducation. Then, post-test scales consisting of the same scales will be administered, and a follow-up test consisting of the same scales will be conducted 2 months later.

Other: Mindfulness-based psychoeducation

Interventions

The experimental group will receive an 8-session mindfulness-based psychoeducation program, administered twice a week for four weeks. Each session of the eight-week program will be 45-60 minutes long. Sessions will be conducted in groups. Following an initial face-to-face meeting to inform the experimental group about the program and schedule meetings, the sessions will continue in person. Each group will consist of 7 people, with a total of 5 groups. Patients will be contacted by phone before each session to remind them of the program time. Immediately after the program sessions are completed, the experimental group will take a post-test. Additionally, follow-up tests will be administered two months after the program is completed. The control group will receive a pre-test followed by no intervention; a post-test will be administered two months later, and follow-up tests two months after the post-test.

experimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering to participate in the study
  • Residing in Gaziantep city center
  • Not having any communication impediments
  • Being between 18 and 65 years of age
  • Being followed up as an outpatient with a diagnosis of depression according to DSM-V criteria
  • Having been receiving treatment for depression for at least 6 months
  • Being literate
  • Not having been enrolled in such an educational program related to their illness within the last 5 years

You may not qualify if:

  • Those diagnosed with another comorbid mental illness
  • Patients with mental conditions that make cooperation impossible, such as intellectual disability or dementia
  • Those who are illiterate
  • Patients who do not consent to the interview
  • Those receiving inpatient treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep Üniversitesi

Gaziantep, şehitkamil, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Songül N Kaplan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants in the experimental group will receive mindfulness-based psychoeducation, and the results will be evaluated by the researcher.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Two groups of patients diagnosed with depressive disorder: an experimental group where mindfulness-based psychoeducation will be applied, and a control group where no intervention will be performed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist nurse

Study Record Dates

First Submitted

March 10, 2026

First Posted

March 20, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

October 1, 2027

Last Updated

March 20, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual patient data will not be shared in order to protect patient privacy and avoid stigmatization.

Locations